BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20260101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270308
DTEND;VALUE=DATE:20270312
DTSTAMP:20261103T120728Z
CREATED:20260925T071331Z
LAST-MODIFIED:20261103T120728Z
UID:44434-1804464000-1804809599@www.pharmajournalist.com
SUMMARY:17th World ADC London
DESCRIPTION:17th World ADC London | 8-11th March 2027 | London\, UK\nThe 17th World ADC London will bring together the global ADC community to explore the science\, strategic insights and partnerships shaping the future of antibody-drug conjugate (ADC) development. Taking place from 8-11th March 2027 in London\, the event will bring together more than 700 leaders from biopharma\, biotech\, academia\, investment and solution provider organisations for Europe’s largest annual gathering dedicated to the ADC community. \nAs ADCs continue to gain momentum across oncology\, the industry faces a new generation of challenges and opportunities. From overcoming resistance mechanisms and improving patient response rates to advancing differentiated designs and scaling manufacturing\, the need for collaboration and knowledge-sharing has never been greater. World ADC London provides a platform for the community to exchange ideas\, learn from emerging data and explore the strategies driving the next wave of innovation. \nThe programme spans the full ADC development journey\, covering discovery\, preclinical and translational development\, clinical development\, process and analytical development\, and manufacturing. Attendees will hear from 110 speakers from across Europe\, North America and Asia\, sharing data-driven insights\, case studies and practical approaches across ADC development. \nWith a strong focus on next-generation ADC innovation and differentiation\, the programme will explore approaches including novel cytotoxic and non-cytotoxic payloads\, dual-payload ADCs and bispecific ADCs\, alongside strategies to move beyond established payloads and targets and advance the next generation of ADCs. \nMore than just a scientific meeting\, World ADC London is recognised as an annual meeting point for the global ADC community. For 17 years\, it has brought together established leaders\, emerging biotech companies\, investors and technology innovators in an environment designed to foster meaningful connections and productive discussions. Whether you are looking to benchmark your strategy\, identify new partners\, discover enabling technologies or gain a broader understanding of the competitive landscape\, the event offers opportunities to connect with the people shaping the field. \nWith extensive networking opportunities\, dedicated partnering experiences and cutting-edge scientific content\, World ADC London remains a key forum for those involved in ADC development. Explore the programme to discover the discussions\, emerging data and connections shaping the next chapter of ADC innovation. \nView the agenda here:  https://ter.li/orip0z61
URL:https://www.pharmajournalist.com/event/17th-world-adc-london/
LOCATION:Novotel London West\, 1 Shortlands\, Hammersmith\, London\, W6 8DR\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR